These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 2827211

  • 1. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
    Lee SC, Ho ST.
    Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
    Kadosaki M, Enzan K, Horiguchi T, Komatsu H, Suzuki M.
    Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of alloferin on neuromuscular function in myasthenia patients undergoing thymectomy.
    Luo X, Yie T, Luo A, Ren H, Jin Y.
    Chin Med Sci J; 1994 Mar; 9(1):56-8. PubMed ID: 8086637
    [Abstract] [Full Text] [Related]

  • 6. Atypical myasthenia gravis. A neurophysiological and pharmacological study.
    Bergmans J, Cleppe D, Diniz P, Rosselle N.
    Electromyogr Clin Neurophysiol; 1975 Jul; 15(3):271-7. PubMed ID: 173519
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of dibutyryl cyclic AMP on neuromuscular transmission in myasthenia gravis.
    Hashimoto Y, Sasaki H, Iwatsuki K.
    Tohoku J Exp Med; 1976 Oct; 120(2):197-8. PubMed ID: 185750
    [Abstract] [Full Text] [Related]

  • 10. Influence of calcium channel blocker drugs in neuromuscular transmission.
    Ozkul Y.
    Clin Neurophysiol; 2007 Sep; 118(9):2005-8. PubMed ID: 17644037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuromuscular transmission in myasthenia gravis studied with single fibre electromyography.
    Stålberg E, Ekstedt J, Broman A.
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):540-7. PubMed ID: 4366058
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Electromyographic characteristics of lysthenon action on neuromuscular transmission in myasthenia patients].
    Kolomenskaia EA, Sigaev VV, Perel'man LB.
    Eksp Khir Anesteziol; 1972 May; 17(4):71-5. PubMed ID: 4345049
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Behavioral of evoked potentials in repeated stimulation of the facial nerve and electromyographic diagnosis of myasthenia gravis].
    Bassi S, Crespi V, Passerini D, Smirne S.
    Riv Neurol; 1975 May; 45(1):60-3. PubMed ID: 167419
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adverse effect of verapamil in myasthenia gravis.
    Swash M, Ingram DA.
    Muscle Nerve; 1992 Mar; 15(3):396-8. PubMed ID: 1557089
    [Abstract] [Full Text] [Related]

  • 20. [A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes (author's transl)].
    Shibuya N.
    Rinsho Shinkeigaku; 1978 Apr; 18(4):177-84. PubMed ID: 212240
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.